In addition, probiotic treatment or FMT can reduce the expression and secretion of inflammatory factors (such as IFN-γ, IL-12, TNF-α, IL-6, and IL-1β) to resist colitis by regulating STAT1, STAT4, or NF-κB signals [57, 58]. This evidence concerns the gene STAT1 and colitis.